Full name
REGEN MEDICINE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.11.Z - Research and experimental development on biotechnology
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Assets | 26,6 | 22,6 | 20,5 | -9,2 |
Gross profit (loss) | -5,1 | -4,2 | -2 | 52,2 |
Net profit (loss) | -5,1 | -4,2 | -2 | 52,2 |
Cash | -55,3 | |||
Net income from sale | -100 | |||
Liabilities and provisions for liabilities | 0,1 | 0,2 | 0,1 | -38,5 |
Short time liabilities | -∞ | |||
Income tax | 0 | 0 | 0 | 0 |
Working assets | 26,6 | 22,6 | 20,5 | -9,2 |
Equity capital | 26,5 | 22,4 | 20,4 | -8,9 |
Operating profit (EBIT) | -185,5 | |||
Basic operational activity income | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -19,3 | -18,6 | -9,8 | 8,8 |
Equity capital to total assets | 99,6 | 99,1 | 99,4 | 0,3 |
Gross profit margin | ||||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane